Allen Jay Robinson

Array ( [id] => 18799390 [patent_doc_number] => RE049742 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-12-05 [patent_title] => Drug delivery system for administration of poorly water soluble pharmaceutically active substances [patent_app_type] => reissue [patent_app_number] => 17/177550 [patent_app_country] => US [patent_app_date] => 2021-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 12162 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17177550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18683223 [patent_doc_number] => RE049687 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-10-10 [patent_title] => Thienopyrimidine and thienopyridine compounds and methods of use thereof [patent_app_type] => reissue [patent_app_number] => 17/165794 [patent_app_country] => US [patent_app_date] => 2021-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 64794 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17165794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18502988 [patent_doc_number] => RE049582 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-07-18 [patent_title] => Therapeutic compounds and compositions [patent_app_type] => reissue [patent_app_number] => 17/131562 [patent_app_country] => US [patent_app_date] => 2020-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 70 [patent_no_of_words] => 60615 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17131562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18699384 [patent_doc_number] => RE049697 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-10-17 [patent_title] => Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations [patent_app_type] => reissue [patent_app_number] => 17/104028 [patent_app_country] => US [patent_app_date] => 2020-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 19054 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19011027 [patent_doc_number] => RE049860 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-03-05 [patent_title] => Process for preparing (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and purification thereof for use as pharmaceutical active ingredient [patent_app_type] => reissue [patent_app_number] => 17/087659 [patent_app_country] => US [patent_app_date] => 2020-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13964 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17087659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18683222 [patent_doc_number] => RE049686 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-10-10 [patent_title] => Nitrogen-containing heterocyclic compound and use of same [patent_app_type] => reissue [patent_app_number] => 17/076227 [patent_app_country] => US [patent_app_date] => 2020-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70750 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17076227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18618463 [patent_doc_number] => RE049647 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-09-12 [patent_title] => Formulations of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione [patent_app_type] => reissue [patent_app_number] => 17/030272 [patent_app_country] => US [patent_app_date] => 2020-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24797 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17030272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18558074 [patent_doc_number] => RE049610 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-08-15 [patent_title] => Heterogeneous catalyst for transesterification and method of preparing same [patent_app_type] => reissue [patent_app_number] => 17/019903 [patent_app_country] => US [patent_app_date] => 2020-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3334 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17019903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18426994 [patent_doc_number] => RE049551 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-06-13 [patent_title] => Heterogeneous catalyst for transesterification and method of preparing same [patent_app_type] => reissue [patent_app_number] => 17/019691 [patent_app_country] => US [patent_app_date] => 2020-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3322 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17019691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18100564 [patent_doc_number] => RE049352 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-01-03 [patent_title] => Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists [patent_app_type] => reissue [patent_app_number] => 17/011592 [patent_app_country] => US [patent_app_date] => 2020-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66591 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17011592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18443045 [patent_doc_number] => RE049555 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-06-20 [patent_title] => Process for producing a stable low concentration, injectable solution of noradrenaline [patent_app_type] => reissue [patent_app_number] => 17/006841 [patent_app_country] => US [patent_app_date] => 2020-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3618 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17006841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18491115 [patent_doc_number] => RE049575 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-07-11 [patent_title] => Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-l,4-dihydro-1-6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredient [patent_app_type] => reissue [patent_app_number] => 17/002115 [patent_app_country] => US [patent_app_date] => 2020-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13965 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17002115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18259203 [patent_doc_number] => RE049466 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-03-21 [patent_title] => Solution phase homogeneous assays [patent_app_type] => reissue [patent_app_number] => 16/945391 [patent_app_country] => US [patent_app_date] => 2020-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26490 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 233 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16945391 [rel_patent_id] =>[rel_patent_doc_number] =>)